‘60 Minutes’ explores promise of CRISPR genome editing

CBS News visits the ӳý for a story on CRISPR genome editing and its potential for medicine.

Feng Zhang and Bill Whitaker at the ӳý
Credit: ӳý Communications
Feng Zhang and Bill Whitaker at the ӳý

On Sunday, April 29, the CBS News program “60 Minutes” aired a piece about CRISPR genome editing and its potential for medicine:

 (A subscription may be required.)

The piece featured interviews with Eric S. Lander, president and founding director of the ӳý, and Feng Zhang, a core institute member, and an investigator at the McGovern Institute for Brain Research at MIT and the James and Patricia Poitras Professor of Neuroscience at MIT.

Learn more about CRISPR and its potential to improve human health on our research highlights page.